Investment Summary

Exits Senomyx

On June 22, 2004, invested in life science company Senomyx from Bay City Capital

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is transaction in the United States.
  • This is transaction in California.
Investment Fate
  • Senomyx was sold to a strategic buyer in 2018.

Investment Summary
Date 2004-06-22
Target Senomyx
Sector Life Science
Sellers(s) Bay City Capital
Deal Type IPO

Target

Senomyx

San Diego, California, United States
website
Senomyx, Inc. is a provider of new and improved proprietary flavor and fragrance molecules for use in a wide range of consumer products. Senomyx’s integrated technology platform combines an enhanced understanding of the biology of taste and smell with many of the same technologies and advancements that pharmaceutical companies have recently begun using to more efficiently discover new medicines. Senomyx, Inc. was founded in 1998 and is based in San Diego, California.

Search 177,960 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor

website

Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.

DEAL STATS #
Overall 13 of 62
Sector (Life Science) 10 of 45
Type (IPO) 7 of 23
State (California) 6 of 33
Country (United States) 13 of 59
Year (2004) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-11-20 Oculex Pharmaceuticals

Sunnyvale, California, United States

Oculex Pharmaceuticals, Inc. is an Ophthalmic drug delivery company.

Sell $230M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-08-01 MAP Pharmaceuticals

Mountain View, California, United States

MAP Pharmaceuticals, Inc. is a specialty pharmaceutical company developing innovative therapies and inhalation delivery platforms to treat a broad spectrum of respiratory and systemic diseases.

Buy -
Mergr

Product

Company

Legal